Seroba Life Sciences Management Limited, and trading as Seroba Life Sciences, is incorporated in Ireland (Company Number: 579226) having its registered office at 18 Herbert Street, Dublin 2, D02 FK19, Ireland. Seroba Life Sciences Management Limited is authorised by the Central Bank of Ireland to act as a EuVECA Manager in accordance with Regulation (EU) No 345/2013 on European venture capital funds and it is also registered with the Central Bank of Ireland as an Alternative Investment Fund Manager under AIFMD (EU Directive 2011/61/EU).

Email Disclaimer:

This information is confidential and may be privileged. It is intended solely for the addressee. Access to this email by any other person (except any person authorised by the addressee to deliver this message to him/her and only for that purpose) is unauthorised. If you are not the addressee you are prohibited from disclosing its content, copying it or distributing it otherwise than to the addressee. Please notify us immediately if you received this email and you are not the addressee and did not receive it to pass to the addressee. If you are not the addressee of this email you should not place any reliance on its contents. If you email information to us, or receive email from us, you should be aware that we cannot give any assurance about the security or confidentiality of any email. We cannot accept responsibility for any loss which may arise to any person as a direct or indirect result of all or any part of any email becoming known by anyone other than the recipient. We have taken precautions to minimize the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any attachment to this message. We cannot accept liability for any loss or damage caused by software viruses.

Please consider the environment before printing this email.

We use cookies and analytics to improve your online experience and to help us to understand where our audience is and how they reach us, as well as to understand what topics and site features are of greatest interest.  To find out more, please read our Privacy Policy. By clicking on the Accept button, you consent to our use of cookies and browsing analytics.

Scroll to Top